VERICEL CORPORATION Accumulated Other Comprehensive Income
VERICEL CORPORATION (VCEL) had Accumulated Other Comprehensive Income of -$365.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-07-30
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$365.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$168.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $275.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $258.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$365.00K 10-Q · filed 2026-07-30 | |
| 2026-03-31 | -$168.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $275.00K 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $258.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $183.00K 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $136.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $4.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $359.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$273.00K 10-Q · filed 2024-08-01 | |
| 2024-03-31 | -$245.00K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | -$100.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | -$463.00K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | -$621.00K 10-Q · filed 2023-08-02 | |
| 2023-03-31 | -$636.00K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | -$978.00K 10-K · filed 2024-02-29 | |
| 2022-09-30 | -$1.15M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | -$855.00K 10-Q · filed 2022-08-03 | |
| 2022-03-31 | -$613.00K 10-Q · filed 2022-05-04 | |
| 2021-12-31 | -$154.00K 10-K · filed 2023-02-23 | |
| 2021-09-30 | -$23.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | -$23.00K 10-Q · filed 2021-08-04 | |
| 2021-03-31 | -$47.00K 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $14.00K 10-K · filed 2022-02-24 | |
| 2020-09-30 | $78.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $146.00K 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $62.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $21.00K 10-K · filed 2021-02-24 | |
| 2019-09-30 | $29.00K 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $38.00K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $3.00K 10-Q · filed 2019-05-07 | |
| 2018-12-31 | -$39.00K 10-K · filed 2020-02-25 | |
| 2018-09-30 | -$18.00K 10-Q · filed 2018-11-06 | |
| 2017-12-31 | $0.00 10-K · filed 2019-02-26 | $397.00K 10-K · filed 2018-03-05 |
| 2016-12-31 | $190.00K 10-K · filed 2018-03-05 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-13 | |
| 2015-09-30 | -$71.00K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | -$71.00K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | -$71.00K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | -$71.00K 10-K · filed 2016-03-14 | |
| 2014-09-30 | -$70.00K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $5.00K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |